Abstract
Objective To investigate the clinical characteristics and treatment strategies of patients with maintenance hemodialysis and tuberculous peritonitis. Methods The clinical data of maintenance hemodialysis 12 patients combined with tuberculous peritonitis were analyzed retrospectively. Results The pathogenesis of maintenance hemodialysis combined with tuberculous peritonitis was concealed, and history of tuberculosis in 4 cases (33%), 10 cases of peripheral blood lymphocyte count 2.5 g/dL, peritoneal effusion ADA>30 U/L in 9 cases (75%), all cases of peritoneal effusion LDH>90 U/L. All 12 patients received two (isoniazid and rifampicin) or triple (isoniazid, rifampicin and ethambutol) anti-tuberculosis treatment, daily single medication for 9 months. Ten patients were discharged with a better health condition. Conclusions Active anti-tuberculosis in the treatment of maintenance hemodialysis patients with tuberculous peritonitis can achieve better results. Key words: Renal Dialysis; Peritonitis, Tuberculous
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
